Message Font: Serif | Sans-Serif
 
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next
Author: MESuther13 Big red star, 1000 posts Old School Fool Add to my Favorite Fools Ignore this person (you won't see their posts anymore) Number: of 33  
Subject: Seattle Times Article Date: 2/12/2005 10:40 AM
Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Recommendations: 0
Here is a link to an article that ran in The Seattle Times on Thursday under the headline "ZymoGenetics on track for final testing of key drug, Thrombin."

You may need to register to view it since it's now in the archives, but it's free if you do.

http://tinyurl.com/6w7bl

Some snippets are below...

Encouraged by earlier tests of a treatment for surgical bleeding, ZymoGenetics plans for the first time to take one of its drugs into the final phase of clinical testing.
The genetically engineered product, Thrombin, is important to ZymoGenetics strategically because it represents the company's initial attempt to develop on its own a product that could gain FDA approval.
Before spinning off as an independent public company in 2000, ZymoGenetics discovered several drugs now on the market, but those were taken through clinical trials at other companies......

ZymoGenetics isn't forecasting the market potential yet for its human version of Thrombin, but it said the cow-derived competitor is expected to reach $165 million in sales this year. Williams said Thrombin could conceivably be used for up to half a million surgeries a year in America, even though the cow-derived product isn't used that widely.
He said ZymoGenetics' product will likely be priced at a premium over the cow-derived version, which commonly sells for $150 per surgery.


MESuther13



Post New | Post Reply | Reply Later | Create Poll Report this Post | Recommend it!
Print the post  
UnThreaded | Threaded | Whole Thread (1) | Ignore Thread Prev | Next

Announcements

Foolanthropy 2014!
By working with young, first-time moms, Nurse-Family Partnership is able to truly change lives – for generations to come.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Post of the Day:
Macro Economics

Looking at Currency Ratios
What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and "#1 Media Company to Work For" (BusinessInsider 2011)! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement